Somatostatin Receptor 1 and/or 4 Selective Agonists and Antagonists
WO2006123020A1
Peptidomimetics selective for the somatostatin receptor subtypes 1 and/or 4
FI20055235A0
Peptidomimetics selective for somatostatin receptor subtypes 1 and / or 4
FI20055236A0
Extremely selective anti-inflammatory and analgesic effects of compounds acting on the SST4 receptor subtype of somatostatin
WO2005082844A1
Treatment of diseases by using a somatostatin receptor agonist
WO2005082845A1
Novel therapies with somatostatin receptor agonists
CA2547863A1
Somatostatin receptor subtype 1 (sstr1) active compounds and their use in therapy
WO2005033068A1
Somatostatin receptor 1 and/or 4 selective agonists and antagonists
WO2004067513A1
Antagonists for alpha-2 adrenoceptors
FI20031824A0
New compounds and their use in therapy
FI20031454A0
Selective somatostatin receptor 1 and / or 4 agonists and antagonists
FI20031456A0
Selective somatostatin receptor 1 and / or 4 agonists and antagonists
FI20031455A0
Sulfonylamino peptidomimetics active against somatostatin receptor subtypes 4 (SSTR4) and 1 (SSTR1)
FI20030026A0
Process for the preparation of substituted imidazole derivatives and in the process useful intermediates
FI20022007A0
Oromucosal preparation and method of preparation thereof
NZ530366A
Compounds useful for treatment or prevention of disease mediated by alpha-2B-adrenoceptor
FI20011560A0
New N-pyrimidinyl para-aminobenzenesulfonamide derivatives as Alpha-2B adrenoceptor antagonists, useful for treating e.g. coronary heart disease, myocardial infarction, angina, restenosis and hypertension
NZ520500A
Sulfonamides useful for the treatment or prevention of a disease i.e. vascular and coronary heart disease mediated by the alpha-2B-adrenoceptor
US6521632B2
Method for the treatment or prevention of a disease mediated by the alpha-2B-adrenoceptor
WO0129082A1
A DNA MOLECULE ENCODING A VARIANT α2B-ADRENOCEPTOR PROTEIN, AND USES THEREOF
